冠心病冠脉病变程度与Apo AI/Apo B、同型半胱氨酸、血脂指标的相关性

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (471 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate and analyze the correlation between the severity of coronary artery disease and apolipoprotein AI/apolipoprotein B (Apo AI/Apo B), homocysteine and blood lipids. Methods From December 2016 to December 2018, 67 patients with coronary heart disease diagnosed by coronary angiography (CAG) admitted to the Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (“our hospital” for short) were selected as the observation group. A total of 63 healthy medical examiners admitted to our hospital at the same time served as the control group. According to the Gensini score, patients with coronary heart disease were divided into low-risk group (n = 23), intermediate-risk group (n = 22) and high-risk group (n = 22). The levels of Apo AI/Apo B, homocysteine, low density lipoprotein, cholesterol and triglyceride in each group were compared to explore the correlation between the severity of coronary artery disease and the indexes of Apo AI/Apo B, homocysteine and blood lipids. Results There were no significant differences in cholesterol and triglyceride levels between the low-risk group, the intermediate-risk group and the high-risk group (P > 0.05). The levels of cholesterol and triglyceride in the low-risk group, the intermediate-risk group and the high-risk group were higher than those in the control group, the differences were statistically significant (P < 0.05). The Apo AI/Apo B in the intermediate-risk group and the high-risk group were lower than the low-risk group, but the homocysteine and low-density lipoprotein levels were higher than the low-risk group, the differences were statistically significant (P < 0.05); Apo AI /Apo B in the high-risk group was lower than the intermediate-risk group, but homocysteine and low density lipoprotein levels were higher than the intermediate-risk group, the differences were statistically significant (P < 0.05). The levels of homocysteine and low density lipoprotein in the low-risk group, the intermediate-risk group and the high-risk group were higher than those in the control group, and the Apo AI/Apo B was lower than that in the control group, the differences were statistically significant (P < 0.05). Apo AI/Apo B was negatively correlated with coronary artery disease (r = -0.189, P < 0.05), and positively correlated with homocysteine and low-density lipoprotein coronary heart disease (r = 0.072-0.095, P < 0.05). Conclusion Apo AI/Apo B, homocysteine and low density lipoprotein levels are correlated with the severity of coronary artery disease, which can be used to predict and judge the disease.

Key words： Coronary heart disease Coronary artery disease Apolipoprotein AI/apolipoprotein B Homocysteine Blood lipid index

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Lin1 SONG Tingting2▲

Cite this article:

LI Lin1 SONG Tingting2▲. Correlation between the degree of coronary artery disease and Apo AI/Apo B, homocysteine and blood lipids[J]. 中国医药导报, 2019, 16(17): 35-38.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2019/V16/I17/35

[1] Kral BG，Kalyani RR，Yanek LR，et al. Relation of Plasma Lipoprotein（a） to Subclinical Coronary Plaque Volumes，Three-Vessel and Left Main Coronary Disease，and Severe Coronary Stenoses in Apparently Healthy African-Americans With a Family History of Early-Onset Coronary Artery Disease [J]. Am J Cardiol，2016，118（5）：656-661.
[2] 艾民，刘广学，颜昌福，等.血脂、血同型半胱氨酸水平与冠状动脉病变程度的相关性研究[J].四川医学，2017，38（9）：10-11.
[3] Kwon SW，Kim JY，Suh YJ，et al. Prognostic Value of Elevated Homocysteine Levels in Korean Patients with Coronary Artery Disease：A Propensity Score Matched Analysis [J]. Korean Circ J，2016，46（2）：154-161.
[4] 王羽．绵阳市老年冠心病患者高同型半胱氨酸血症界定值研究[J].四川医学，2014，35（12）：1519-1521.
[5] Kim BJ，Kim BS，Kang JH. Plasma homocysteine and coronary artery calcification in Korean men [J]. Eur J Prev Cardiol，2015，22（4）：478-485.
[6] 高磊，刘昱圻，薛桥，等．高龄急性冠状动脉综合征经桡动脉冠状动脉介入治疗的疗效和安全性观察[J].中华医学杂志，2014，26（6）：2025-2029.
[7] de Sá Ferreira A. Plasma Homocysteine and Arterial Stiffness：Risk Factors or Risk Markers for Cardiovascular Diseases [J]. J Clin Hypertens，2015，17（8）：601-602.
[8] 简冬冬，高传玉，李牧蔚，等.磺达肝癸钠与依诺肝素在中国人急性冠脉综合征PCI 术后疗效及安全性的前瞻性研究[J].实用医学杂志，2014，30（5）：812-815.
[9] 杨礼文，夏豪，田国卫，等.经皮冠状动脉介入术后患者血清hs-CRP、SAA水平与冠状动脉支架内再狭窄的相关分析[J].疑难病杂志，2017，16（6）：541-544，549.
[10] 杨兰，冯爽，韩艳丽.老年冠心病患者血清Angptl2、Angptl4水平与冠状动脉狭窄程度的关系[J].临床和实验医学杂志，2018，17（24）：2629-2633.
[11] 张培培，孙魁，刘爱萍，等.老年冠心病患者同型半胱氨酸、尿酸与冠状动脉狭窄及左心功能的相关性探讨[J].临床和实验医学杂志，2017，16（3）：221-225.
[12] 王妮.血栓通注射液对急性冠脉综合征患者介入术后血脂、炎症因子及内皮功能的影响[J].现代中西医结合杂志，2017，26（7）：728-729.
[13] Van Dijk SC，Enneman AW，Swart KM，et al. Effects of 2-year vitamin B12 and folic acid supplementation inhyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial [J]. J Hypertens，2015，33（9）：1897-1906.
[14] 刘浙波，夏豪，王建铭，等.经皮冠状动脉介入治疗术前白蛋白水平与冠状动脉病变程度及支架内再狭窄的关系[J].中华实用诊断与治疗杂志，2016，30（6）：123-124.
[15] 孟广斌.血清同型半胱氨酸、血脂、尿酸与冠状动脉狭窄程度相关性研究[J].检验医学与临床，2017，14（9）：12-13.
[16] 魏庆民，程敏静，程敏菊，等.急性冠状动脉综合征患者髓过氧化物酶和同型半胱氨酸水平与预后的关系研究[J].中国医学装备，2018，15（1）：81-84.
[17] 吴和弟，许丽娃，吉家钗，等.2型糖尿病合并冠心病患者血清PCT、hs-CRP及血脂水平与冠状动脉病变的关系分析[J].疑难病杂志，2018，17（10）：1094-1098.
[18] 李健，杨治平，张国盛，等.血栓通联合低分子肝素治疗高龄急性冠脉综合征介入治疗术后患者临床分析[J].内科，2016，13（1）：178-179.
[19] 宋艳东，陶英，王苏，等.冠心病患者同型半胱氨酸、血尿酸水平与冠脉病变的相关性[J].中华急诊医学杂志，2017，26（4）：345-346.
[20] 赵鹏，王玮玮，宋执敬.血浆同型半胱氨酸水平与冠心病患者冠脉病变程度的相关性研究[J].河北医药，2016， 38（11）：450-451.
[21] 宋艳东，陶英，王苏，等.冠心病患者同型半胱氨酸、血尿酸水平与冠脉病变的相关性[J].中华急诊医学杂志，2017，26（4）：23-24.
[22] 孟光斌.血清同型半胱氨酸、血脂、尿酸与冠状动脉狭窄程度相关性研究[J].检验医学与临床，2017，14（9）：561-562.
[23] 刘鹏，高学良，原建华，等.H型高血压患者血清同型半胱氨酸水平与冠状动脉狭窄病变程度的关系[J].中华老年心脑血管病杂志，2017，19（3）：118-119.
[24] 许真真，梁红久.血清同型半胱氨酸与冠脉病变严重程度相关性研究[J].泰山医学院学报，2016，37（9）：103-104.
[25] 张燕妮.老年冠心病患者冠脉病变严重程度与血清UA及Hcy水平的相关性[J].心脑血管康复医学杂志，2017， 26（4）：568-569.